120 related articles for article (PubMed ID: 9267276)
1. Staphylococcus epidermidis graft infection is associated with locally suppressed major histocompatibility complex class II and elevated MAC-1 expression.
Henke PK; Bergamini TM; Garrison JR; Brittian KR; Peyton JC; Lam TM
Arch Surg; 1997 Aug; 132(8):894-902. PubMed ID: 9267276
[TBL] [Abstract][Full Text] [Related]
2. Infection of vascular prostheses caused by bacterial biofilms.
Bergamini TM; Bandyk DF; Govostis D; Kaebnick HW; Towne JB
J Vasc Surg; 1988 Jan; 7(1):21-30. PubMed ID: 2961893
[TBL] [Abstract][Full Text] [Related]
3. Bacterial products primarily mediate fibroblast inhibition in biomaterial infection.
Henke PK; Bergamini TM; Watson AL; Brittian KR; Powell DW; Peyton JC
J Surg Res; 1998 Jan; 74(1):17-22. PubMed ID: 9536967
[TBL] [Abstract][Full Text] [Related]
4. Development of a Staphylococcus epidermidis vascular graft infection model in sheep.
Sardelic F; Peng YA; Fletcher JP
Aust N Z J Surg; 1995 Jul; 65(7):503-6. PubMed ID: 7611972
[TBL] [Abstract][Full Text] [Related]
5. The effect of protein binding on the adherence of staphylococci to prosthetic vascular grafts.
Malangoni MA; Livingston DH; Peyton JC
J Surg Res; 1993 Feb; 54(2):168-72. PubMed ID: 8479177
[TBL] [Abstract][Full Text] [Related]
6. The effect of aspirin on adherence of slime-producing, coagulase-negative staphylococci to vascular grafts.
Demirag MK; Esen S; Zivalioglu M; Leblebicioglu H; Keceligil HT
Ann Vasc Surg; 2007 Jul; 21(4):464-7. PubMed ID: 17628264
[TBL] [Abstract][Full Text] [Related]
7. The natural history of bacterial biofilm graft infection.
Bergamini TM; Corpus RA; Brittian KR; Peyton JC; Cheadle WG
J Surg Res; 1994 May; 56(5):393-6. PubMed ID: 8170137
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 modulates monocyte MHC-II (Ia) suppression in biomaterial infection.
Henke PK; Bergamini TM; Brittian KR; Polk HC
J Surg Res; 1997 May; 69(2):372-8. PubMed ID: 9224410
[TBL] [Abstract][Full Text] [Related]
9. Treatment of bacteria-biofilm graft infection by in situ replacement in normal and immune-deficient states.
Bandyk DF; Kinney EV; Riefsnyder TI; Kelly H; Towne JB
J Vasc Surg; 1993 Sep; 18(3):398-405; discussion 405-6. PubMed ID: 8104253
[TBL] [Abstract][Full Text] [Related]
10. Gelatin-sealed dacron graft is not more susceptible to MRSA infection than PTFE graft.
Yasim A; Gul M; Ciralik H; Ergun Y
Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):425-30. PubMed ID: 16725356
[TBL] [Abstract][Full Text] [Related]
11. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppression augments growth of graft-adherent Staphylococcus epidermidis.
Bergamini TM; Corpus RA; McCurry TM; Peyton JC; Brittian KR; Cheadle WG
Arch Surg; 1995 Dec; 130(12):1345-50. PubMed ID: 7492284
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-sealed Dacron.
Sardelic F; Ao PY; Taylor DA; Fletcher JP
Cardiovasc Surg; 1996 Jun; 4(3):389-92. PubMed ID: 8782944
[TBL] [Abstract][Full Text] [Related]
14. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
[TBL] [Abstract][Full Text] [Related]
15. Influence of some plasma proteins on in vitro bacterial adherence to PTFE and Dacron vascular prostheses.
Zdanowski Z; Ribbe E; Schalén C
APMIS; 1993 Dec; 101(12):926-32. PubMed ID: 8110449
[TBL] [Abstract][Full Text] [Related]
16. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft.
Goëau-Brissonnière O; Mercier F; Nicolas MH; Bacourt F; Coggia M; Lebrault C; Pechère JC
J Vasc Surg; 1994 Apr; 19(4):739-41. PubMed ID: 8164289
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells have significant anti-infective effect on methicillin-resistant Staphylococcus epidermidis vascular graft infections.
Canbeyli İD; Kabalcı M; Çırpar M; Tiryaki M; Oktaş B
Eklem Hastalik Cerrahisi; 2019 Dec; 30(3):201-11. PubMed ID: 31650915
[TBL] [Abstract][Full Text] [Related]
18. Local application of vancomycin for prophylaxis of graft infection: release of vancomycin from antibiotic-bonded Dacron grafts, toxicity in endothelial cell culture, and efficacy against graft infection in an animal model.
Muhl E; Gatermann S; Iven H; Dendorfer A; Bruch HP
Ann Vasc Surg; 1996 May; 10(3):244-53. PubMed ID: 8792993
[TBL] [Abstract][Full Text] [Related]
19. Sonication provides maximal recovery of staphylococcus epidermidis from slime-coated vascular prosthetics.
Wengrovitz M; Spangler S; Martin LF
Am Surg; 1991 Mar; 57(3):161-4. PubMed ID: 1825907
[TBL] [Abstract][Full Text] [Related]
20. Identification of Staphylococcus epidermidis vascular graft infections: a comparison of culture techniques.
Bergamini TM; Bandyk DF; Govostis D; Vetsch R; Towne JB
J Vasc Surg; 1989 May; 9(5):665-70. PubMed ID: 2524605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
